Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

783
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
783
Introduction to Hemostasis01:05

Introduction to Hemostasis

8.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.5K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

12
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
12
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

8.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.5K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Vascular Spasm01:16

Vascular Spasm

1.6K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparable Survivorship and Patient-Reported Outcomes Following Unicompartmental Knee Arthroplasty in Obese and Non-Obese Patients: An Updated Systematic Review.

The Journal of arthroplasty·2026
Same author

The "Distal Femoral Replacement Downgrade": Technique of Using Bicondylar Femoral Cones With a Hinge Total Knee Arthroplasty Revision in Patients Who Have Massive Distal Femoral Bone Loss as an Alternative.

The Journal of arthroplasty·2026
Same author

Dogma Under the Knife: Challenging the Status Quo in Primary Total Knee Arthroplasty.

The Journal of arthroplasty·2026
Same author

Subsidence Starts Distally: Scaffolding Versus Reconstitution Closure of the Extended Trochanteric Osteotomy in Revision Total Hip Arthroplasty.

The Journal of arthroplasty·2026
Same author

Systematic Review of Wound Complications After Direct Anterior Approach Total Hip Arthroplasty: Incidence, Risk Factors, and Management Strategies.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same author

Low Heterotopic Ossification Recurrence Following Surgical Excision in a Total Hip Arthroplasty Population.

The Journal of arthroplasty·2026

Related Experiment Video

Updated: Aug 2, 2025

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
04:20

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma

Published on: July 28, 2020

5.3K

Hemostatic Agents in Orthopedic Surgery.

Kira K Tanghe1, Brian P Chalmers2, Jason L Blevins2

  • 1Albert Einstein College of Medicine, Bronx, NY, USA.

HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery
|April 17, 2023
PubMed
Summary
This summary is machine-generated.

Effective hemostasis in orthopedic surgery involves using various agents to control blood loss. This review details mechanical, active, flowable hemostats, and fibrin sealants for optimal intraoperative bleeding management.

Keywords:
blood losshemostasishemostatic agentshemostatsorthopedics

More Related Videos

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.3K
A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

335

Related Experiment Videos

Last Updated: Aug 2, 2025

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
04:20

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma

Published on: July 28, 2020

5.3K
Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.3K
A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

335

Area of Science:

  • Orthopedic Surgery
  • Surgical Hemostasis

Background:

  • Controlling intraoperative blood loss is critical in orthopedic procedures.
  • Hemostatic agents, often combined with antifibrinolytics, are key to managing bleeding.
  • New hemostatic agents, initially for vascular surgery, are now used in orthopedics.

Purpose of the Study:

  • To review the mechanisms of action and optimal applications of different hemostatic agents in orthopedic surgery.
  • To guide the selection of appropriate hemostatic strategies for various orthopedic bleeding scenarios.

Main Methods:

  • Review of current literature on hemostatic agents used in orthopedic surgery.
  • Categorization of hemostats into mechanical, active, flowable, and fibrin sealants.
  • Analysis of reported efficacy and specific use cases for each category.

Main Results:

  • Mechanical and active hemostats effectively reduce bleeding from cancellous bone, capillaries, and venules.
  • Flowable hemostats are advantageous in confined surgical spaces, avoiding detrimental swelling.
  • Fibrin sealants are best suited for closing tissue defects and providing definitive closure.

Conclusions:

  • A range of hemostatic agents are available for orthopedic surgery, each with specific applications.
  • Understanding the properties of mechanical, active, flowable hemostats, and sealants optimizes bleeding control.
  • Appropriate selection and use of these agents contribute to improved patient outcomes by minimizing blood loss.